BIM-018

BIM-018
Legal status
Legal status	CA: Schedule II ;
Identifiers
	IUPAC name 2-(naphthalene-1-carbonyl)-1-pentyl-1H-1,3-benzodiazole;
ChemSpider	29763750;
UNII	2FNW3VE8P9;
Chemical and physical data
Formula	C23H22N2O
Molar mass	342.4 g/mol g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CCCCCn1c2ccccc2nc1C(=O)c1cccc2c1cccc2;
	InChI InChI=1S/C23H22N2O/c1-2-3-8-16-25-21-15-7-6-14-20(21)24-23(25)22(26)19-13-9-11-17-10-4-5-12-18(17)19/h4-7,9-15H,2-3,8,16H2,1H3; Key:ZJWSSWFQIOEVCU-UHFFFAOYSA-N;

BIM-018 is a synthetic cannabinoid that is the benzimidazole analog of JWH-018. It is presumed to be a potent agonist of the CB₂ receptor and has been sold online as a designer drug.[1]

Related benzimidazole derivatives have been reported to be highly selective agonists for the CB₂ receptor.[2]

References

"BIM-018". Cayman Chemical. Retrieved 24 July 2015.
Daniel Pagé; Elise Balaux; Luc Boisvert; Ziping Liu; Claire Milburn; Maxime Tremblay; Zhongyong Wei; Simon Woo; Xuehong Luo; Yun-Xing Cheng; Hua Yang; Sanjay Srivastava; Fei Zhou; William Brown; Miroslaw Tomaszewski; Christopher Walpole; Leila Hodzic; Stéphane St-Onge; Claude Godbout; Dominic Salois; Keymal Payza (July 2008). "Novel benzimidazole derivatives as selective CB₂ agonists". Bioorganic & Medicinal Chemistry Letters. 18 (13): 3695–3700. doi:10.1016/j.bmcl.2008.05.073. PMID 18522867.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.